Abstract: Disclosed are systems and associated methods for calculating and displaying formation flight information, to include aircraft spacing, predicted trajectory data, collision avoidance alerts, time on target details, and chalk-specific information, on an augmented reality display designed to interface with aviation helmets. Two or more networked computing devices, each on a separate aircraft, collect some combination of aircraft altitude, location, and inertial data, preform certain calculations, and then develops a virtual overlay according to aircraft relative position and nearby aircraft trajectories. The virtual overlay is further informed by compass and gyroscopic data from an operatively coupled augmented reality display device. The developed virtual overlay is then transmitted to the display device for viewing by the pilot.

Abstract: Strains of Cryptococcus flavescens which are superior antagonists of F. graminearum for suppression and control of FHB in cereals, particularly in wheat and barley, are described. The strains are prothioconazole tolerant variants of previously described C. flavescens OH 182.9 (NRRL Y-30216). Moreover, these prothioconazole tolerant variants exhibit significantly increased efficacy against F. graminearum in comparison to the parent strain OH 182.9.

Abstract: A method and system are provided by the present invention for testing performance validity and accuracy of functional elements of a computer application. A stand-alone test tool provides an environment in which the operation of the functional element can be monitored along with a plurality of interfaces between the functional element and the computer application. The test tool permits creation of a test data file which can be viewed and edited as desired outside of the test tool environment, and permits creation of a test case generation file with the user assisted by prompts as to interface task options. In a preferred embodiment a test cooperates with an interface protocol of a type involving a memory shared by multiple functional elements and employing a mode of notifying an addressed functional element that data is ready and of specifying the location of the data in the shared memory.

Abstract: Enzymes and methods suitable for assaying ATP, and specific application for such assays are described and claimed. In particular, there is described a recombinant mutant luciferase having a mutation for example, in the amino-acid corresponding to amino acid residue number 245 in Photinus pyralis, is such that the Km for ATP of the luciferase is increased e.g. five-fold with respect to that of the corresponding non-mutated enzyme such that it is of the order of 500 &mgr;m-1 mM. Also disclosed are luciferases having additional mutations conferring improved thermostability or altered wavelength of emitted light. Recombinant polynucleotides, vectors and host cells are also disclosed, as are methods of assaying the amount of ATP in a material (e.g. cells) optionally in real-time. Also disclosed are test-kits for in vitro assays.

Abstract: Hydantoin derivatives of varying lipophilic character were prepared as nigen mustard carriers for CNS anti-tumor evaluation in transplanted mouse tumor test systems. Activity was studied in the murine ependymoblastoma brain tumor system. Multiple cures were observed for three of the four analogs examined. The compounds were also active in the intraperitoneal leukemia L1210 and P388 systems as well as in B16 melanoma and Lewis lung carcinoma.

Abstract: A gas stream containing carbon monoxide and hydrogen is methanated by pasg the gas stream upwardly through a suspension of a finely divided hydrogenation catalyst in a fluidizing medium. The reaction takes place at a temperature of from 450 to 950.degree. F.

Abstract: The subject invention is directed to an apparatus which selectively contr the rate with which a drug contained therein is released to surrounding tissue. Moreover, the subject invention is directed to process for controlling said release which comprises sealing the end of a suitable vessel with a non-porous material, inserting into said vessel a suitable medicament, and sealing the opposite end thereof with a porous neutral hydrogel through which naturally occuring materials can diffuse and further through which said medicament may diffuse.